META Named to 2025 Deloitte China Seed Award for Pharmaceutical & Health List – META

SCIENCE

LDHA

PIPELINE

NEWS

CONTACT US

Honor

2025.12.19

META Named to 2025 Deloitte China Seed Award for Pharmaceutical & Health List

New 251219

Deloitte China has recently announced its 2025 Technology Fast Program lists. META stood out among numerous outstanding applicants, earning a place on the 2025 Deloitte China Seed Award for Pharmaceutical & Health list, recognized for its pioneering innovation in immunometabolism, substantial R&D translational capabilities, and significant technological potential.

Prev Back to list Next

Related News

China Central Media Highlights META at ASGH with HKSTP “World-First” Recognition

China Central Media Highlights META at ASGH with HKSTP “World-First” Recognition

The 6th Asian Healthcare Summit (ASGH), a flagship event of International Healthcare Week, was held on May 11–12, 2026, at the Hong Kong Convention and Exhibition Centre.

META Nominates MP-5342 as First Pre-clinical Candidate for Inflammatory Bowel Disease 2025/10/15

META Nominates MP-5342 as First Pre-clinical Candidate for Inflammatory Bowel Disease 2025/10/15

The first candidate molecule derived from the innovative immunometabolism platform has completed preclinical development and is approaching the IND-enabling study stage.

META Spotlight | META Invited to Present at J.P. Morgan Innovation House

META Spotlight | META Invited to Present at J.P. Morgan Innovation House

Recently, Dr. Anjin Xianyu, CTO of META, was invited to attend the J.P. Morgan Innovation House event in Hong Kong. During the Company Spotlight session, he presented the company, further expanding exchanges and connections with regional innovation and investment ecosystem partners.

Discovery Begins Asking How Life Works

Copyright © 2026 Meta Pharmaceuticals Inc.
粤ICP备2026058060号